| [May 03, 2012] |
 |
Imperva Announces First Quarter 2012 Financial Results
REDWOOD SHORES, Calif. --(Business Wire)--
Imperva, Inc. (NYSE: IMPV), a pioneer and leader of a new category of
data security solutions for high-value business data in the data center,
today announced financial results for the first quarter ended March 31,
2012.
"We had a strong start to the year driven by growing demand for our
comprehensive, fully integrated solution along with solid sales of
recently launched products," stated Shlomo Kramer, President and Chief
Executive Officer of Imperva. "We performed well across all of our key
operating metrics as we leveraged the investments made in our global
sales infrastructure and continued to gain traction with our channel
partners. Looking ahead, with a healthy pipeline of business and
expanding product line, we believe that we are well positioned to expand
our share in the growing data center security market."
First Quarter 2012 Financial Highlights
-
Revenue: Total revenue for the first quarter of 2012 was $21.5
million, an increase of 31% compared to $16.4 million in the first
quarter of 2011. Within total revenue, product revenue was $12.1
million, an increase of 21% compared to the first quarter of 2011.
Services revenue increased 47% year over year to $9.4 million and
accounted for 44% of total revenue, up from 39% in the first quarter
of 2011. Within service revenue, overall subscription revenue grew
203% to $670,000 compared to the first quarter of 2011.
-
Operating Loss: Operating loss as reported in accordance with
U.S. generally accepted accounting principles (GAAP) was $3.2 million
for the first quarter compared to a loss of $3.1 million during the
first quarter in 2011. GAAP results included stock-based compensation
expense of $0.7 million for the first quarter of 2012 and $0.3 million
for the first quarter of 2011. Non-GAAP operating loss for the first
quarter was $2.5 million, compared to a loss of $2.8 million during
the same period in 2011, excluding the above mentioned charges.
-
Net Loss: GAAP net loss attributable to Imperva stockholders
for the first quarter was $3.3 million, or $0.15 per share based on
22.3 million weighted average diluted shares outstanding. This
compares to GAAP net loss attributable to Imperva stockholders of $3.2
million, or $0.63 per share based on 5.1 million weighted average
shares outstanding in the prior-year period.
Non-GAAP net
loss attributable to Imperva stockholders for the first quarter of
2012 was $2.6 million, or $0.12 per share based on 22.3 million
weighted average diluted shares outstanding, excluding the above
mentioned charges. This compares to non-GAAP net loss attributable to
Imperva stockholders of $2.9 million, or $0.18 per share based on 15.8
million weighted average diluted shares outstanding in the prior year
period.
Both GAAP and non-GAAP loss per share attributable
to Imperva stockholders for the first quarter ended March 31, 2012
adjust for the loss attributable to Imperva's non controlling interest
in Incapsula. A reconciliation of GAAP to non-GAAP financial measures
has been provided in the financial statement tables included in this
press release. An explanation of these measures is also included below
under the heading "Non-GAAP Financial Measures."
-
Balance Sheet: As of March 31, 2012, Imperva had cash, cash
equivalents and investments of $100.6 million.
First Quarter 2012 Operating Highlights
-
The number of deals booked with a value over $100,000 increased 73%
year over year to 57 during the first quarter.
-
Total deferred revenue of $35.2 million was up 52% compared to $23.1
million in the prior year period.
-
The company added 89 new customers during the quarter and now has over
1,800 customers in more than 50 countries around the world.
-
Imperva released its latest Hacker Intelligence Initiative report
exploring how Local and Remote File Inclusion (RFI/LFI) attacks enable
hackers to execute malicious code and steal data through the
manipulation of a company's web server.
-
Imperva analyzed a high-profile 'Anonymous' attack using its
Application Defense Center (ADC), which reported on the attack from
start to finish.
Business Outlook
The following forward-looking statements reflect expectations as of May
3, 2012. Results may be materially different and could be affected by
the factors detailed in this press release and in recent Imperva SEC
filings.
Second Quarter Expectations - Ending June 30, 2012
Imperva expects total revenue for the second quarter of 2012 to be in
the range of $23.3 million to $23.8 million, representing growth in the
range of 24% to 26% compared to the same period in 2011. The company
expects in the second quarter of 2012 non-GAAP gross margins of
approximately 79%. Further, Imperva expects in the second quarter of
2012 non-GAAP operating loss to be in the range of $1.2 million to $1.4
million and non-GAAP net loss attributable to Imperva stockholders to be
in the range of $1.1 million to $1.3 million, or a loss of $0.04 to
$0.05 per share, which excludes stock-based compensation expense.
Full Year Expectations -Ending December 31, 2012
Imperva expects total revenue for 2012 to be in the range of $98.0
million to $100.0 million, or up 25% to 28% compared to 2011. Imperva
expects in 2012 non-GAAP gross margins of approximately 80%. Further,
the company expects in 2012 non-GAAP operating loss to be in the range
of $3.3 million to $3.7 million and non-GAAP net loss attributable to
Imperva stockholders to be in the range of $2.8 million to $3.2 million,
or a loss of $0.12 to $0.14, which excludes stock-based compensation
expense. Imperva expects capital expenditures for the full year to be in
the range of $2.0 million to $2.5 million. Finally, the company expects
to generate positive cash flow from operations in 2012.
Quarterly Conference Call
Imperva will host a conference call today at 2:00 p.m. Pacific Time
(5:00 p.m. Eastern Time) to review the company's financial results for
the first quarter ended March 31, 2012. To access this call, dial
800.967.7141 for the U.S. and Canada or 719.457.2643 for international
callers with conference ID #1471551. A live webcast of the conference
call will be accessible from the investors page of Imperva's website at www.imperva.com,
and a recording will be archived and accessible at www.imperva.com.
An audio replay of this conference call will also be available through
May 17, 2012, by dialing 877.870.5176 for the U.S. and Canada, or
858.384.5517 for international callers and entering passcode 1471551.
Non-GAAP Financial Measures
Imperva reports all financial information required in accordance with
generally accepted accounting principles (GAAP). To supplement the
Imperva unaudited condensed consolidated financial statements presented
in accordance with GAAP, Imperva uses certain non-GAAP measures of
financial performance. The presentation of these non-GAAP financial
measures is not intended to be considered in isolation from, as a
substitute for, or superior to, the financial information prepared and
presented in accordance with GAAP, and may be different from non-GAAP
financial measures used by other companies. In addition, these non-GAAP
measures have limitations in that they do not reflect all of the amounts
associated with the results of Imperva operations as determined in
accordance with GAAP. The non-GAAP financial measures used by Imperva
include historical non-GAAP net loss and non-GAAP basic and diluted loss
per share. These non-GAAP financial measures exclude stock-based
compensation from the Imperva unaudited condensed consolidated statement
of operations and give pro forma effect to the conversion of convertible
preferred stock and issuance of common stock in connection with
Imperva's initial public offering as if both had happened at the
beginning of each period presented.
For a description of these items, including the reasons why management
adjusts for them, and reconciliations of these non-GAAP financial
measures to the most directly comparable GAAP financial measures, please
see the section of the accompanying tables titled "Use of Non-GAAP
Financial Information" as well as the related tables that precede it.
Imperva may consider whether other significant non-recurring items that
arise in the future should also be excluded in calculating the non-GAAP
financial measures it uses.
Imperva believes that these non-GAAP financial measures, when taken
together with the corresponding GAAP financial measures, provide
meaningful supplemental information regarding the performance of Imperva
by excluding certain items that may not be indicative of the company's
core business, operating results or future outlook. Imperva management
uses, and believes that investors benefit from referring to, these
non-GAAP financial measures in assessing operating results of Imperva,
as well as when planning, forecasting and analyzing future periods.
These non-GAAP financial measures also facilitate comparisons of the
performance of Imperva to prior periods.
Extension of Lock-Up Period
In connection with the company's initial public offering, the
underwriters and certain holders of Imperva common stock entered into
agreements restricting the sale or transfer of shares of common stock
during the 180-day period following the date of the IPO prospectus.
These agreements provide for an automatic extension in the event the
company announces that it will release financial results or other
material news within the last 17 days of the lock-up period or the
15-day period following the originally-scheduled expiration of the
agreements (to instead extend through the 18-day period beginning on the
issuance of the earnings release or the announcement of the material
news or material event). These agreements were originally scheduled to
expire on May 6, 2012. As a result of the company's release of its
financial results today, the lock-up agreements described above will be
automatically extended through May 20, 2012.
Forward Looking Statements
This press release contains forward-looking statements, including
without limitation those regarding Imperva's "Business Outlook" ("Second
Quarter Expectations - Ending June 30, 2012" and "Full Year Expectations
- Ending December 31, 2012"); Imperva's expectations regarding growing
demand for its comprehensive, fully integrated solution; the company's
belief that it will continue to gain traction with its channel partners;
Imperva's belief that its pipeline of business and expanding product
line up will continue to expand; the company's belief that it is well
positioned to expand its share in the growing data center security
market; and Imperva's belief that the data center security market will
grow quickly. These forward-looking statements are subject to material
risks and uncertainties that may cause actual results to differ
substantially from expectations. Investors should consider important
risk factors, which include: the risk that demand for our data security
solutions may not increase and may decrease; the risk that we may not
timely introduce new products or versions of our products and that they
may not be accepted by the market; the risk that competitors may be
perceived by customers to be better positioned to help handle data
security threats and protect their businesses from major risk; the risk
that the growth of Imperva may be lower than anticipated; and other
risks detailed under the caption "Risk Factors" in the company's Form
10-K filed with the Securities and Exchange Commission, or the SEC, on
March 28, 2012 and the company's other SEC filings. You can obtain
copies of the company's SEC filings on the SEC's website at www.sec.gov.
The foregoing information represents the company's outlook only as of
the date of this press release, and Imperva undertakes no obligation to
update or revise any forward-looking statements, whether as a result of
new information, new developments or otherwise.
About Imperva
Imperva is a pioneer and leader of a new category of data security
solutions for high-value business data in the data center. With more
than 1,800 end-user customers and thousands of organizations protected
through cloud-based deployments, Imperva's customers include leading
enterprises, government organizations, and managed service providers who
rely on Imperva to prevent sensitive data theft from hackers and
insiders. The award-winning Imperva SecureSphere identifies and secures
high-value data across file systems, web applications and databases. For
more information, visit www.imperva.com,
follow us on Twitter
or visit our blog.
© 2012 Imperva, Inc. All rights reserved. Imperva, the Imperva logo and
SecureSphere are trademarks of Imperva, Inc.
|
|
|
|
|
IMPERVA, INC. AND SUBSIDIARIES
|
|
Condensed Consolidated Statements of Operations
|
|
(On a GAAP basis)
|
|
(In thousands, except per share amounts)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|
|
|
March 31,
|
|
|
|
March 31,
|
|
|
|
|
|
|
|
2012
|
|
|
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
|
|
Products and license
|
|
|
|
|
$
|
12,052
|
|
|
|
$
|
9,978
|
|
|
Services
|
|
|
|
|
|
9,466
|
|
|
|
|
6,445
|
|
|
Total net revenue
|
|
|
|
|
|
21,518
|
|
|
|
|
16,423
|
|
|
Cost of revenue(1):
|
|
|
|
|
|
|
|
|
|
|
|
Products and license
|
|
|
|
|
|
1,854
|
|
|
|
|
1,371
|
|
|
Services
|
|
|
|
|
|
2,733
|
|
|
|
|
1,963
|
|
|
Total cost of revenue
|
|
|
|
|
|
4,587
|
|
|
|
|
3,334
|
|
|
Gross profit
|
|
|
|
|
|
16,931
|
|
|
|
|
13,089
|
|
|
Operating expenses(1):
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
|
|
4,993
|
|
|
|
|
3,927
|
|
|
Sales and marketing
|
|
|
|
|
|
11,596
|
|
|
|
|
10,000
|
|
|
General and administrative
|
|
|
|
|
|
3,493
|
|
|
|
|
2,294
|
|
|
Total operating expenses
|
|
|
|
|
|
20,082
|
|
|
|
|
16,221
|
|
|
Loss from operations
|
|
|
|
|
|
(3,151
|
)
|
|
|
|
(3,132
|
)
|
|
Other income (expense), net
|
|
|
|
|
|
(70
|
)
|
|
|
|
(89
|
)
|
|
Loss before provision for income taxes
|
|
|
|
|
|
(3,221
|
)
|
|
|
|
(3,221
|
)
|
|
Provision for income taxes
|
|
|
|
|
|
153
|
|
|
|
|
116
|
|
|
Net loss
|
|
|
|
|
|
(3,374
|
)
|
|
|
|
(3,337
|
)
|
|
Loss attributable to noncontrolling interest
|
|
|
|
|
|
103
|
|
|
|
|
131
|
|
|
Net loss attributable to Imperva, Inc. stockholders
|
|
|
|
|
$
|
(3,271
|
)
|
|
|
$
|
(3,206
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share of common stock attributable to
|
|
|
|
|
|
|
|
|
|
|
|
Imperva, Inc. stockholders, basic and diluted
|
|
|
|
|
$
|
(0.15
|
)
|
|
|
$
|
(0.63
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing net loss per share of common stock, basic
and diluted
|
|
|
|
|
|
22,304
|
|
|
|
|
5,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Stock-based compensation expense as included in above:
|
|
|
|
Cost of revenue
|
|
|
|
|
$
|
55
|
|
|
|
$
|
18
|
|
|
Research and development
|
|
|
|
|
|
127
|
|
|
|
|
18
|
|
|
Sales and marketing
|
|
|
|
|
|
261
|
|
|
|
|
58
|
|
|
General and administrative
|
|
|
|
|
|
225
|
|
|
|
|
189
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense
|
|
|
|
|
$
|
668
|
|
|
|
$
|
283
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IMPERVA, INC. AND SUBSIDIARIES
|
|
Condensed Consolidated Balance Sheets
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
As of
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
|
|
|
|
2012
|
|
|
|
2011
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
$
|
64,968
|
|
|
$
|
96,025
|
|
|
Short-term investments
|
|
|
|
|
|
35,584
|
|
|
|
1,587
|
|
|
Restricted cash, current
|
|
|
|
|
|
587
|
|
|
|
687
|
|
|
Accounts receivable, net
|
|
|
|
|
|
19,456
|
|
|
|
25,736
|
|
|
Inventory
|
|
|
|
|
|
325
|
|
|
|
442
|
|
|
Deferred tax assets
|
|
|
|
|
|
261
|
|
|
|
246
|
|
|
Prepaid expenses and other current assets
|
|
|
|
|
|
2,022
|
|
|
|
1,352
|
|
|
Total current assets
|
|
|
|
|
|
123,203
|
|
|
|
126,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
|
|
3,859
|
|
|
|
4,026
|
|
|
Severance pay fund
|
|
|
|
|
|
2,663
|
|
|
|
2,652
|
|
|
Restricted cash
|
|
|
|
|
|
666
|
|
|
|
666
|
|
|
Deferred tax assets
|
|
|
|
|
|
46
|
|
|
|
46
|
|
|
Other assets
|
|
|
|
|
|
377
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
$
|
130,814
|
|
|
$
|
133,542
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities, convertible preferred stock and stockholders' equity
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
|
|
$
|
2,420
|
|
|
$
|
3,534
|
|
|
Accrued compensation and benefits
|
|
|
|
|
|
6,566
|
|
|
|
7,491
|
|
|
Accrued and other current liabilities
|
|
|
|
|
|
3,187
|
|
|
|
4,408
|
|
|
Deferred revenue
|
|
|
|
|
|
24,346
|
|
|
|
21,982
|
|
|
Total current liabilities
|
|
|
|
|
|
36,519
|
|
|
|
37,415
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities
|
|
|
|
|
|
2,578
|
|
|
|
2,856
|
|
|
Deferred revenue
|
|
|
|
|
|
10,805
|
|
|
|
10,943
|
|
|
Accrued severance pay
|
|
|
|
|
|
3,097
|
|
|
|
2,760
|
|
|
Total liabilities
|
|
|
|
|
|
52,999
|
|
|
|
53,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
|
|
|
2
|
|
|
|
2
|
|
|
Additional paid-in capital
|
|
|
|
|
|
147,822
|
|
|
|
147,085
|
|
|
Accumulated deficit
|
|
|
|
|
|
(69,401
|
)
|
|
|
(66,130
|
)
|
|
Accumulated other comprehensive income (loss)
|
|
|
|
|
|
94
|
|
|
|
(616
|
)
|
|
Total Imperva, Inc. stockholders' equity
|
|
|
|
|
|
78,517
|
|
|
|
80,341
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Noncontrolling interest
|
|
|
|
|
|
(702
|
)
|
|
|
(773
|
)
|
|
Total stockholders' equity
|
|
|
|
|
|
77,815
|
|
|
|
79,568
|
|
|
Total liabilities, convertible preferred stock and stockholders'
equity
|
|
|
|
|
$
|
130,814
|
|
|
$
|
133,542
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IMPERVA, INC. AND SUBSIDIARIES
|
|
Condensed Consolidated Statements of Cash Flows
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
|
|
|
|
2012
|
|
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
$
|
(3,374
|
)
|
|
$
|
(3,337
|
)
|
Adjustments to reconcile net loss to net cash provided by operating
activities:
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
411
|
|
|
|
368
|
|
|
Stock-based compensation
|
|
|
|
|
|
668
|
|
|
|
283
|
|
|
Revaluation of convertible preferred stock warrant liability
|
|
|
|
|
|
-
|
|
|
|
1
|
|
|
Amortization/accretion of premiums/discounts on ST investments
|
|
|
|
|
|
76
|
|
|
|
-
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
|
|
|
6,280
|
|
|
|
2,652
|
|
|
Inventory
|
|
|
|
|
|
117
|
|
|
|
(155
|
)
|
|
Prepaid expenses and other assets
|
|
|
|
|
|
(14
|
)
|
|
|
(796
|
)
|
|
Accounts payable
|
|
|
|
|
|
(1,114
|
)
|
|
|
253
|
|
|
Accrued compensation and benefits
|
|
|
|
|
|
(925
|
)
|
|
|
(582
|
)
|
|
Accrued and other liabilities
|
|
|
|
|
|
(1,359
|
)
|
|
|
476
|
|
|
Severance pay, net
|
|
|
|
|
|
326
|
|
|
|
35
|
|
|
Deferred revenue
|
|
|
|
|
|
2,226
|
|
|
|
1,929
|
|
|
Deferred tax assets
|
|
|
|
|
|
(15
|
)
|
|
|
(76
|
)
|
|
Other
|
|
|
|
|
|
(4
|
)
|
|
|
43
|
|
|
Net cash provided by operating activities
|
|
|
|
|
|
3,299
|
|
|
|
1,094
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
Purchase of short-term investments
|
|
|
|
|
|
(34,903
|
)
|
|
|
(367
|
)
|
|
Proceeds from maturities of short-term investments
|
|
|
|
|
|
925
|
|
|
|
526
|
|
|
Purchase of property and equipment
|
|
|
|
|
|
(244
|
)
|
|
|
(380
|
)
|
|
Change in other assets
|
|
|
|
|
|
(300
|
)
|
|
|
-
|
|
|
Change in restricted cash
|
|
|
|
|
|
100
|
|
|
|
705
|
|
|
Net cash provided by (used in) investing activities
|
|
|
|
|
|
(34,422
|
)
|
|
|
484
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options
|
|
|
|
|
|
103
|
|
|
|
280
|
|
|
Repayment of revolving credit facility
|
|
|
|
|
|
-
|
|
|
|
(501
|
)
|
|
Net cash provided by (used in) financing activities
|
|
|
|
|
|
103
|
|
|
|
(221
|
)
|
|
Effect of exchange rate changes on cash
|
|
|
|
|
|
(37
|
)
|
|
|
19
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
|
|
|
(31,057
|
)
|
|
|
1,376
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
$
|
96,025
|
|
|
$
|
16,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
|
|
|
$
|
64,968
|
|
|
$
|
17,786
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IMPERVA, INC. AND SUBSIDIARIES
|
|
(Reconciliation of GAAP to Non-GAAP Measures)
|
|
(In thousands, except per share amounts)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
|
|
|
|
2012
|
|
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating loss
|
|
|
|
|
$
|
(3,151
|
)
|
|
$
|
(3,132
|
)
|
|
Plus:
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
668
|
|
|
|
283
|
|
|
Non-GAAP operating loss
|
|
|
|
|
$
|
(2,483
|
)
|
|
$
|
(2,849
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss attributable to Imperva, Inc. stockholders
|
|
|
|
|
$
|
(3,271
|
)
|
|
$
|
(3,206
|
)
|
|
Plus:
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
668
|
|
|
|
283
|
|
|
Non-GAAP net loss
|
|
|
|
|
$
|
(2,603
|
)
|
|
$
|
(2,923
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding, basic and diluted
|
|
|
|
|
|
22,304
|
|
|
|
5,075
|
|
|
Plus:
|
|
|
|
|
|
|
|
|
|
|
Additional weighted average shares giving effect to initial
public offering and conversion of convertible preferred stock
at the beginning of the period
|
|
|
|
|
|
-
|
|
|
|
10,761
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing Non-GAAP net loss per share, basic and
diluted
|
|
|
|
|
|
22,304
|
|
|
|
15,836
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net loss, basic and diluted
|
|
|
|
|
$
|
(0.12
|
)
|
|
$
|
(0.18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Due to rounding to the nearest tenth of a percent, totals may
not equal the sum of the line items in the table above.
|
|
|
|
|
Use of Non-GAAP Financial Information
In addition to the reasons stated above, which are generally applicable
to each of the items Imperva excludes from its non-GAAP financial
measures, Imperva believes it is appropriate to exclude or give effect
to certain items for the following reasons:
Stock-Based Compensation: When evaluating the performance of its
consolidated results, Imperva does not consider stock-based compensation
charges. Likewise, the Imperva management team excludes stock-based
compensation expense from its operating plans. In contrast, the Imperva
management team is held accountable for cash-based compensation and such
amounts are included in its operating plans. Further, when considering
the impact of equity award grants, Imperva places a greater emphasis on
overall stockholder dilution rather than the accounting charges
associated with such grants.
Imperva believes it is useful to provide a non-GAAP financial measure
that excludes stock-based compensation in order to better understand the
long-term performance of its business.
Conversion of Preferred and Shares from Initial Public Offering:
Imperva believes it is useful to provide a non-GAAP financial measure
that gives pro forma effect to the conversion of preferred stock and
issuance of common stock in connection with Imperva's initial public
offering as if both had happened at the beginning of each period
presented in order to have an alternative way to evaluate per share
performance on a comparative basis.

[ Back To TMCnet.com's Homepage ]
|